| 英文名称 |
中文名称 |
CAS |
|
AMC-01
|
|
1047978-71-1 |
|
GPX4-IN-6
|
|
2922824-07-3 |
|
9(S)-HOTrE
|
|
89886-42-0 |
|
Saccharocarcin A
|
|
158475-32-2 |
|
MCTR3
|
|
1784701-63-8 |
|
Docosane
|
|
629-97-0 |
|
GSK046
|
|
2474876-09-8 |
|
Eclitasertib
|
|
2125450-76-0 |
|
NF-κΒ activator 1
|
|
2387524-59-4 |
|
Caroverine hydrochloride
|
|
55750-05-5 |
|
Semax acetate(80714-61-0 free base)
|
|
2828433-33-4 |
|
PCSK9 Protein, Human, Recombinant (D374Y & V474I & G670E, His)
|
|
|
|
SI 60
|
|
133152-67-7 |
|
Vanillic acid glucoside
|
|
32142-31-7 |
|
Trastuzumab deruxtecan
|
|
1826843-81-5 |
|
Kansuinine A
|
|
57701-86-7 |
|
10'-Desmethoxystreptonigrin
|
|
136803-89-9 |
|
SDZ 220-040 ammonium
|
|
|
|
(R)-Naroparcil
|
|
252647-51-1 |
|
25-Desacetyl Rifampicin
|
|
16783-99-6 |
|
CA77.1
|
|
2412270-22-3 |
|
Shepherdin 79-87 acetate
|
|
|
|
SGK1-IN-4
|
|
1628048-93-0 |
|
Arofylline
|
|
136145-07-8 |
|
11β-HSD1-IN-12
|
|
872506-67-7 |
|
Gantofiban
|
|
183547-57-1 |
|
1-Palmitoyl Lysophosphatidic Acid (sodium salt)
|
|
17618-08-5 |
|
1-(3-chloropyridin-2-yl)piperazine 2HCl
|
|
1193389-39-7 |
|
CIA-1 (Free base)
|
|
452087-38-6 |
|
C2-8
|
|
300670-16-0 |
|
CAY10770
|
|
2428734-45-4 |
|
PKI 14-22 amide, myristoylated Acetate
|
|
|
|
PF-07258669
|
|
2755890-53-8 |
|
(±)5(6)-EpETE methyl ester
|
|
127716-49-8 |
|
17-hydroxy Venturicidin A
|
|
113204-43-6 |
|
5-Aminothalidomide
|
|
191732-76-0 |
|
SXC 2023
|
|
1695562-36-7 |
|
DiR iodide
|
|
|
|
AT-121
|
|
2099681-31-7 |
|
2,3-dihydro-1H-indene-5-sulfonamide
|
|
35203-93-1 |
|
PD-1/PD-L1-IN-9
|
|
2628506-54-5 |
|
Ciamexon
|
|
75985-31-8 |
|
Uridine-5'-monophosphate (sodium salt hydrate)
|
|
681435-27-8 |
|
EM-12
|
|
26581-81-7 |
|
Rel-TREM2 agonist-2
|
|
2738485-99-7 |
|
PACMA 31
|
|
1401089-31-3 |
|
Protonstatin-1
|
|
521972-99-6 |
|
ATG7-IN-1
|
|
2226229-87-2 |
|
Venadaparib
|
|
1681017-83-3 |
|
ANT3310
|
|
2410688-61-6 |
|
DPTN dihydrochloride
|
|
325767-87-1 |
|
GGACK (hydrochloride)
|
|
|
|
Complement C5 Protein, Human, Recombinant (Complement C5a)
|
|
|
|
Scandoside
|
|
18842-99-4 |
|
Nexinhib20
|
|
331949-35-0 |
|
Secoisolariciresinol diglucoside
|
|
158932-33-3 |
|
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester
|
|
195503-20-9 |
|
PRX-07034 hydrochloride
|
|
903580-39-2 |
|
CL 218872
|
|
66548-69-4 |
|
Aurora kinase inhibitor-2
|
|
331770-21-9 |
|
1,2,3-Trilinoelaidoyl-rac-glycerol
|
|
5188-25-0 |
|
Methyl 3,4-Dihydroxyphenylacetate
|
|
25379-88-8 |
|
13(S)-HpOTrE(γ)
|
|
121107-97-9 |
|
(R)-Monepantel
|
|
887148-70-1 |
|
sbp-7455
|
|
1884222-74-5 |
|
IMB-XMA0038
|
|
921812-26-2 |
|
Solpecainol
|
|
155321-96-3 |
|
Arecoline
|
|
63-75-2 |
|
SphK1&2-IN-1
|
|
1415662-57-5 |
|
11β-HSD1 inibitor 19
|
|
946400-19-7 |
|
GV-150013X
|
|
151386-96-8 |
|
Kukoamine B mesylate
|
|
1375179-86-4 |
|
3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid
|
|
300816-42-6 |
|
PD 198306
|
|
212631-61-3 |
|
Pinolenic Acid ethyl ester
|
|
493015-74-0 |
|
BMS-488043
|
|
452296-83-2 |
|
Azomethine-H monosodium
|
|
5941-07-1 |
|
Dihydrosinapyl alcohol
|
|
20736-25-8 |
|
CYM2503
|
|
1308833-36-4 |
|
Rhod-2 (sodium salt)
|
|
|
|
GSK-3β inhibitor 10
|
|
1198098-03-1 |
|
1,3-BUTANEDIOL
|
|
107-88-0 |
|
Pomisartan 2HCl
|
|
|
|
1,3,6,8-Tetrahydroxynaphthalene
|
|
18512-30-6 |
|
CYP2A6-IN-1
|
|
912291-11-3 |
|
ABC34
|
|
1831135-56-8 |
|
Dihydro Montelukast
|
|
142147-67-9 |
|
Calcifediol monohydrate
|
|
63283-36-3 |
|
Vantictumab
|
|
1345009-45-1 |
|
Ibritumomab
|
|
|
|
Tazomeline
|
|
131987-54-7 |
|
α-Conotoxin GI acetate
|
|
|
|
MBP MAPK Substrate acetate
|
|
|
|
6'-hydroxydihydrocinchonidine
|
|
5962-19-6 |
|
Qa-1b&B2M&Qdm (AMAPRTLLL) Monomer Protein, Mouse, MHC (His & Avi)
|
|
|
|
4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid
|
|
199167-79-8 |
|
Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside
|
|
205370-59-8 |
|
1,4-DPCA
|
|
331830-20-7 |
|
4-Nitrophenyl dodecanoate
|
|
1956-11-2 |
|
AVG-233
|
|
2151937-80-1 |
